These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27813692)

  • 1. Memantine for the Treatment of Phantom Limb Pain: A Systematic Review.
    Loy BM; Britt RB; Brown JN
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):276-283. PubMed ID: 27813692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain.
    Wiech K; Kiefer RT; Töpfner S; Preissl H; Braun C; Unertl K; Flor H; Birbaumer N
    Anesth Analg; 2004 Feb; 98(2):408-413. PubMed ID: 14742379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial.
    Maier C; Dertwinkel R; Mansourian N; Hosbach I; Schwenkreis P; Senne I; Skipka G; Zenz M; Tegenthoff M
    Pain; 2003 Jun; 103(3):277-283. PubMed ID: 12791434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
    Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
    Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine for the treatment of general neuropathic pain: a narrative review.
    Pickering G; Morel V
    Fundam Clin Pharmacol; 2018 Feb; 32(1):4-13. PubMed ID: 28802070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain.
    Hackworth RJ; Tokarz KA; Fowler IM; Wallace SC; Stedje-Larsen ET
    Anesth Analg; 2008 Oct; 107(4):1377-9. PubMed ID: 18806054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of memantine in the prophylactic treatment of episodic migraine: A systematic review.
    Mistry VM; Morizio PL; Pepin MJ; Bryan WE; Brown JN
    Headache; 2021 Sep; 61(8):1207-1213. PubMed ID: 34352118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study.
    Nikolajsen L; Gottrup H; Kristensen AG; Jensen TS
    Anesth Analg; 2000 Oct; 91(4):960-6. PubMed ID: 11004057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Memantine and Complex Regional Pain Syndrome (CRPS): effects of treatment and cortical reorganisation].
    Sinis N; Birbaumer N; Schwarz A; Gustin S; Unertl K; Schaller HE; Haerle M
    Handchir Mikrochir Plast Chir; 2006 Jun; 38(3):164-71. PubMed ID: 16883501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of memantine for neuropathic pain.
    Buvanendran A; Kroin JS
    Anesth Analg; 2008 Oct; 107(4):1093-4. PubMed ID: 18806007
    [No Abstract]   [Full Text] [Related]  

  • 11. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA-mediated mechanisms in cortical excitability changes after limb amputation.
    Schwenkreis P; Maier C; Pleger B; Mansourian N; Dertwinkel R; Malin JP; Tegenthoff M; Zenz M
    Acta Neurol Scand; 2003 Sep; 108(3):179-84. PubMed ID: 12911461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year phantom limb pain with only four sessions of Fu's subcutaneous needling: A case report and systematic review.
    Huang H; Yu Y; Peng Y; Fu Z
    Explore (NY); 2024; 20(4):513-519. PubMed ID: 38008590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin in the Treatment of Phantom Limb Pain: A Systematic Review.
    Neumüller J; Lang-Illievich K; Brenna CTA; Klivinyi C; Bornemann-Cimenti H
    CNS Drugs; 2023 Jun; 37(6):513-521. PubMed ID: 37261670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine. Merz.
    Kilpatrick GJ; Tilbrook GS
    Curr Opin Investig Drugs; 2002 May; 3(5):798-806. PubMed ID: 12090556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment.
    McCormick Z; Chang-Chien G; Marshall B; Huang M; Harden RN
    Pain Med; 2014 Feb; 15(2):292-305. PubMed ID: 24224475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of memantine in combination with alcohol in moderate drinkers.
    Bisaga A; Evans SM
    Psychopharmacology (Berl); 2004 Feb; 172(1):16-24. PubMed ID: 14530901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.
    Mitchell AC
    J Pain Symptom Manage; 2001 May; 21(5):443-6. PubMed ID: 11369165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
    Peskind ER; Potkin SG; Pomara N; Ott BR; Graham SM; Olin JT; McDonald S
    Am J Geriatr Psychiatry; 2006 Aug; 14(8):704-15. PubMed ID: 16861375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.